The FDA has updated warnings about potential cardiac risks associated with Pfizer and Moderna COVID-19 vaccines, especially for young men. Learn what the new labels say and what it means for vaccine safety.
Pfizer Inc. has decided to stop the development of its obesity pill, danuglipron, after safety concerns emerged from a clinical trial. This move comes as competition heats up with Novo Nordisk and Eli Lilly's successful weight-loss treatments.
A recent study reveals that Paxlovid, Pfizer's antiviral treatment for COVID-19, may not significantly reduce hospitalizations or deaths in vaccinated older adults. Researchers express surprise at the findings, urging caution in treatment decisions for this demographic.
